Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V0114CP versus placebo and desloratadine for seasonal allergic rhinitis
2008-000133-22Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of V0114CP in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Reflective nasal symptom score. Started Mar 2008; status: completed.
02
Drugs
V0114CP
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2008-000133-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000133-22.